GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (FRA:4YL) » Definitions » Ending Cash Position

Nanoform Finland (FRA:4YL) Ending Cash Position : €36.47 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Ending Cash Position?

Nanoform Finland's Ending Cash Position for the quarter that ended in Dec. 2024 was €36.47 Mil.

Nanoform Finland's quarterly Ending Cash Position increased from Jun. 2024 (€30.46 Mil) to Sep. 2024 (€33.16 Mil) and increased from Sep. 2024 (€33.16 Mil) to Dec. 2024 (€36.47 Mil).

Nanoform Finland's annual Ending Cash Position declined from Dec. 2022 (€68.74 Mil) to Dec. 2023 (€14.23 Mil) but then increased from Dec. 2023 (€14.23 Mil) to Dec. 2024 (€36.47 Mil).


Nanoform Finland Ending Cash Position Historical Data

The historical data trend for Nanoform Finland's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoform Finland Ending Cash Position Chart

Nanoform Finland Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 61.03 75.73 68.74 14.23 36.47

Nanoform Finland Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.23 13.42 30.46 33.16 36.47

Nanoform Finland Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nanoform Finland's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=14.231+22.24
=36.47

Nanoform Finland's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=33.158+3.313
=36.47


Nanoform Finland Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nanoform Finland's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanoform Finland Business Description

Traded in Other Exchanges
Address
Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceuticals pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.

Nanoform Finland Headlines

No Headlines